Platelet hitchhiking vascular-disrupting agents for self-amplified tumor-targeting therapy
{{output}}
The vascular-disrupting agent DMXAA (5,6-dimethylxanthone-4-acetic acid) exhibits potent anticancer activity by targeting tumor vasculature and activating immune responses via the cGAS-STING pathway. However, its clinical application is hindered by nonspecific... ...
